difference between a semaglutide and tirzepatide vs. for Weight Loss Semaglutide vs Tirzepatide for Weight

In the SURMOUNT-1 trial, patients on the highest tirzepatide dose lost an average of 22.5 percent of their body weight over 72 weeks

Drug-Disease Interactions: Rybelsus 14 mg Tablet may interact with disease conditions, including suicidal behaviour and ideation, thyroid cancer, GI adverse events, hypoglycaemia, pancreatitis and retinopathy

Patients in our weight management program, at least initially, are required to come to the clinic to receive their injections weekly so they have an opportunity to have consistent weights, waist measurements, and vitals assessed

This includes your prescription, medical supplies, menu(s), and personalized coaching

Since risks and monitoring needs vary by individual and by GLP-1 drug, you should rely on your clinician for personalized guidance and instructions